Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/dscm) is investigating potential claims against the board of directors of drugstore.com, inc. ("drugstore.com" or the "Company") (NASDAQ: DSCM) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s efforts to sell drugstore.com to Walgreen Co. in a transaction valued at approximately $409 million.

Our investigation concerns possible breaches of fiduciary duty and other violations of law related to the approval of the transaction by Company’s board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of drugstore.com. For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at rmaniskas@rmclasslaw.com or visit: www.rmclasslaw.com/cases/dscm.

Under the terms of the definitive agreement, drugstore.com shareholders will receive $3.80 per share for each share of drugstrore.com stock that they own.

If you own shares of drugstore.com and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/dscm. You may also email Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.

Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.

Drugstore (NASDAQ:DSCM)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Drugstore Charts.
Drugstore (NASDAQ:DSCM)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Drugstore Charts.